Home  >  News
  Lexicon to present new clinical data for sotagliflozin at 78th ADA scientific sessions,   June 20, 2018
  Arrowhead completes enrollment in phase 1 study of ARO-AAT to treatalpha-1 liver disease,   June 20, 2018
  NIH to end funding for moderate alcohol and cardiovascular health trial,   June 19, 2018
  Alcon AcrySof IQ PanOptix IOL shows superior visual performance in head-to-head trial post-cataract surgery,   June 19, 2018
  Daiichi Sankyo presents positive results from QuANTUM-R phase 3 study of single agent quizartinib at EHA congress,   June 19, 2018
  Teva updates ENFORCE phase III clinical trial of fremanezumab for use in chronic cluster headache,   June 18, 2018
  Novartis announces positive results from JULIET trial of Kymriah to treat adults with relapsed/refractory DLBCL,   June 18, 2018
  US FDA approves BlueWind's pivotal trial design of Renova iStim implantable tibial nerve neuromodulator for OAB,   June 18, 2018
  NIH begins investigational RSV vaccine trial,   June 18, 2018
  MorphoSys presents data from phase 2 COSMOS trial of blood cancer drug candidate MOR208 in CLL and SLL at EHA 2018 meeting,   June 16, 2018
  Prana to initiate phase 1 trial of PBT434 to treat Parkinsonian diseases,   June 16, 2018
  Luminex begins clinical trials for Verigene II gastrointestinal assay,   June 16, 2018
  Roche announces positive data from CLL11 study evaluating Gazyva/Gazyvaro to treat previously untreated CLL,   June 16, 2018
  Novartis phase III RESPONSE Jakavi comparison study shows reduction in risk of death, blood clots for patients with rare blood cancer,   June 16, 2018
  Novotech inks MoU with China Medical University Hospital in Taiwan to offer enhanced services for global trials,   June 15, 2018
  Akcea completes landmark study to assess disease burden in people living with FCS,   June 15, 2018
  ViiV Healthcare announces phase III GEMINI studies of dolutegravir and lamivudine meets primary endpoint,   June 15, 2018
  Seattle Genetics begins patient dosing in phase 2 trial of innovaTV 204,   June 15, 2018
  CStone Pharma starts two pivotal phase II studies of anti-PD-L1 monoclonal antibody CS1001,   June 14, 2018
  MorphoSys begins patient enrollment in phase 3 trial of gantenerumab to treat Alzheimer's disease,   June 14, 2018

cphikorea_150x60_saffron media
Copyright © 2016 Saffron Media Pvt. Ltd |